BioCentury
ARTICLE | Clinical News

Lipofen fenofibrate capsules regulatory update

January 16, 2006 8:00 AM UTC

FDA approved an NDA for 50, 100 and 150 mg Lipofen gelatine capsules containing fenofibrate as an adjunctive therapy to diet to reduce elevated LDL-C, total cholesterol, triglycerides, apolipoprotein...